SCHEMBL207874

SCHEMBL207874

COc1ccc(NC(=O)CCC(=O)NC2CCC(Cc3ccc(Cl)cc3)(N(C)C)CC2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.55
MEN1 O00255 4/20 0.55
KLK7 P49862 1/20 0.47
ALDH1A1 P00352 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
CXCR6 O00574 1/20 0.47
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
HPGD P15428 1/20 0.45
CYP2C19 P33261 1/20 0.45
HTT P42858 1/20 0.45
CCR1 P32246 1/20 0.44
EPHX2 P34913 1/20 0.44
FPR2 P25090 2/20 0.43
CNR1 P21554 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
AVPR1A P37288 1/20 0.43
ALOX12 P18054 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5160624 0.88 LMNA (0.43) KMT2AMEN1ALDH1A1L3MBTL1CYP2C9
SCHEMBL206649 0.86 ENPP2 (0.44) KMT2AMEN1ALDH1A1L3MBTL1CYP2C9
SCHEMBL207100 0.84 NPSR1 (0.43) KMT2AMEN1ALDH1A1L3MBTL1HPGD
SCHEMBL209344 0.84 ALDH1A1 (0.42) KMT2AMEN1ALDH1A1L3MBTL1CYP1A2
SCHEMBL4074093 0.84 MEN1 (0.38) KMT2AMEN1ALDH1A1L3MBTL1HPGD
SCHEMBL206987 0.83 POLB (0.56) KMT2AMEN1CYP1A2CYP3A4CYP2D6
Butane SCHEMBL4074088 0.83 MEN1 (0.38) KMT2AMEN1ALDH1A1L3MBTL1HPGD
SCHEMBL206932 0.82 LMNA (0.46) KMT2AMEN1ALDH1A1L3MBTL1CYP1A2
SCHEMBL206354 0.81 MEN1 (0.49) KMT2AMEN1ALDH1A1CYP1A2CYP3A4
SCHEMBL2989386 0.81 LMNA (0.45) CYP1A2CYP3A4CYP2D6CYP2C9HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088763-B2 e.g. N-[1-(2,6-dichloro-benzyl)-pyrrolidin-3-yl]-N'-[4-dimethylamino-4-(4-methyl-benzyl)-cyclohexyl]-succinamide; noradrenaline and serotonin reuptake ihibitor; opioid ORL-1 receptor ligand; analgesic, antidepressant, anxiolytic agent, neurodegenerative diseases GRUENENTHAL GMBH (DE) 2012-01-03 US claimed
EP-1745010-B1 SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES GRUENENTHAL GMBH (DE) 2009-08-05 EP claimed
US-20070112007-A1 Cyclohexyl-1, 4-diamine compounds GRUENENTHAL GMBH (DE) 2007-05-17 US claimed
US-8088763-B2 e.g. N-[1-(2,6-dichloro-benzyl)-pyrrolidin-3-yl]-N'-[4-dimethylamino-4-(4-methyl-benzyl)-cyclohexyl]-succinamide; noradrenaline and serotonin reuptake ihibitor; opioid ORL-1 receptor ligand; analgesic, antidepressant, anxiolytic agent, neurodegenerative diseases GRUENENTHAL GMBH (DE) 2012-01-03 US disclosed
EP-1745010-B1 SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES GRUENENTHAL GMBH (DE) 2009-08-05 EP disclosed
US-20070112007-A1 Cyclohexyl-1, 4-diamine compounds GRUENENTHAL GMBH (DE) 2007-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112007-A1 Cyclohexyl-1, 4-diamine compounds PKD1, DDC, DPYD KMT2A 3604/4885MEN1 713/4885KLK7 2657/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.